OncoMed Pharmaceuticals Announces Bayer Terminates its Option to License Vantictumab or Ipafricept
Apr 10, 2017 12:08 pm UTC| Business
REDWOOD CITY, Calif., April 10, 2017 -- OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer stem cell and immuno-oncology...
OncoMed Pharmaceuticals Announces Bayer Terminates its Option to License Vantictumab or Ipafricept
Apr 10, 2017 12:08 pm UTC| Business
REDWOOD CITY, Calif., April 10, 2017 -- OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer stem cell and immuno-oncology...
OncoMed Pharmaceuticals Announces Bayer Terminates its Option to License Vantictumab or Ipafricept
Apr 10, 2017 12:08 pm UTC| Business
REDWOOD CITY, Calif., April 10, 2017 -- OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer stem cell and immuno-oncology...
Dow Jones launches Data, News and Analytics (DNA) Platform
Apr 10, 2017 12:07 pm UTC| Business
Provides customers and partners with access to world-class Dow Jones news and data for workflow integration and the development of new information solutionsNow in public beta, DNA has been made available on platforms...
OncoMed Pharmaceuticals Announces Bayer Terminates its Option to License Vantictumab or Ipafricept
Apr 10, 2017 12:08 pm UTC| Business
REDWOOD CITY, Calif., April 10, 2017 -- OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer stem cell and immuno-oncology...
OncoMed Pharmaceuticals Announces Bayer Terminates its Option to License Vantictumab or Ipafricept
Apr 10, 2017 12:08 pm UTC| Business
REDWOOD CITY, Calif., April 10, 2017 -- OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer stem cell and immuno-oncology...
Dow Jones launches Data, News and Analytics (DNA) Platform
Apr 10, 2017 12:07 pm UTC| Business
Provides customers and partners with access to world-class Dow Jones news and data for workflow integration and the development of new information solutionsNow in public beta, DNA has been made available on platforms...